About

PMC's Annual Award for Leadership in Personalized Medicine

Jay Flatley, Executive Chairman, Illumina (right), accepts the 13th Annual Award for Leadership in Personalized Medicine from Paul R. Billings, M.D., Ph.D., Chairman, Biological Dynamics, at Harvard Medical School.

2018 Call for Nominations

PMC is now accepting nominations for the 14th Annual Award for Leadership in Personalized Medicine. The award recognizes an individual whose contributions in science, business and/or policy have helped advance the frontiers of personalized medicine.

PMC will present the award during the 14th Annual Personalized Medicine Conference, which will take place from November 14 - 15 at Harvard Medical School. The recipient will share his or her vision for the future of personalized medicine.

To nominate a leader, please email a letter of nomination explaining how your nominee has advanced personalized medicine along with a brief bio of the nominee to Christopher J. Wells, Vice President, Public Affairs, at cwells@personalizedmedicinecoalition.org. Nominations are due April 13, 2018.

Previous award recipients include:

• Jay T. Flatley (2017)
  Executive Chairman
  Illumina
  
• Raju Kucherlapati, Ph.D. (2016)
  Paul C. Cabot Professor of Genetics
  Harvard Medical School
  
• Francis S. Collins, M.D., Ph.D. (2015)
  Director
  National Institutes of Health (NIH)
  
• Mark Levin (2014)
  Co-founder, Partner
  Third Rock Ventures
  
• Kathy Giusti (2013)
  Founder, Chief Executive Officer
  Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortium
  
• Randal W. Scott, Ph.D. (2012)
  Co-Founder
  InVitae Corporation
• Leroy Hood, Ph.D., M.D. (2011)
  President
  Institute for Systems Biology
• William S. Dalton, Ph.D., M.D. (2010)
  CEO
  M2GEN
  Director
  DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center
• Brook Byers (2009)
  Managing Partner
  Kleiner Perkins Caufield & Byers (KPCB)
• Michael O. Leavitt (2008)
  Founder and Chairman
  Leavitt Partners
• Ralph Snyderman, M.D. (2007)
  Chancellor Emeritus
  Duke University
  Founder and Chairman
  Proventys, Inc.
  
• Elizabeth G. Nabel, M.D. (2006)
  President
  Brigham and Women's Health Care
• Janet Woodcock, M.D. (2005)
  Director
  FDA Center for Drug Evaluation and Research